Achilles Therapeutics plc Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Achilles Therapeutics plc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • Achilles Therapeutics plc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.43M, a 17.7% increase year-over-year.
  • Achilles Therapeutics plc annual Nonoperating Income (Expense) for 2023 was $6.08M, a 16.9% decline from 2022.
  • Achilles Therapeutics plc annual Nonoperating Income (Expense) for 2022 was $7.32M, a 134% increase from 2021.
  • Achilles Therapeutics plc annual Nonoperating Income (Expense) for 2021 was $3.13M, a 490% increase from 2020.
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.08M -$1.24M -16.9% Jan 1, 2023 Dec 31, 2023 20-F 2024-04-04
2022 $7.32M +$4.19M +134% Jan 1, 2022 Dec 31, 2022 20-F 2024-04-04
2021 $3.13M +$2.6M +490% Jan 1, 2021 Dec 31, 2021 20-F 2024-04-04
2020 $531K +$746K Jan 1, 2020 Dec 31, 2020 20-F 2023-03-07
2019 -$215K Jan 1, 2019 Dec 31, 2019 20-F 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.